Browsing by Author "Ridler A"

Now showing 1 - 3 of 3

An observational study of farmer-reported clinical mastitis in New Zealand dairy ewes.
(Taylor and Francis Group, 2024-07-01) Chambers G; Laven R; Grinberg A; Ridler A; Velathanthiri N
AIMS: To describe the incidence, aetiology, treatment, and outcomes of farmer-reported clinical mastitis on New Zealand dairy sheep farms. METHODS: A prospective cohort study was conducted on 20 spring-lambing New Zealand sheep milking farms over the 2022-2023 season. Clinical mastitis was defined as a change in the appearance of milk and/or signs of inflammation in the gland. Farmers were required to report all cases of clinical mastitis and collect information on affected ewes' demographics, clinical features, treatments (where applicable), and outcomes. Milk samples from mastitic glands were submitted for microbiological culture and identification by matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry (MALDI-TOF). RESULTS: Partial or complete clinical mastitis data were available for 236 cases from 221 ewes on 18/20 study farms. Clinical mastitis was diagnosed in 0-6% of ewes at the farm level, with an overall incidence of 1.8 (95% CI = 1.0-3.2)% using the study data, or 2.3 (95% CI = 1.6-3.3)% using the study data and farmer estimates that included unreported cases. Cases occurred mostly in early lactation, with 59% detected during the lambing period (August-October), at a median of 7 (IQR 3, 40) days in milk. The majority of cases featured clots in the milk (59%), swelling (55%), and unevenness (71%) of the glands. Pyrexia (rectal temperature ≥ 40.0°C) was diagnosed in 25% of cases and depression (lethargy, inappetence, or inability to stand) in 26% of cases. Treatment was given to 46% of cases, with tylosin being the most commonly used treatment (50% of treated cases). The most common outcome was immediate drying off to be culled without treatment (32%), followed by still milking and recovered but with lasting problems (25%). Nearly half of all the milk samples submitted were culture negative. Streptococcus uberis (14%), non-aureus staphylococci (12%), and Staphylococcus aureus (11%) were the most common isolates, found on 12, 8 and 8 of the 16 farms with microbiological data, respectively. CONCLUSIONS: Clinical mastitis affected up to 6% of ewes at the farm level. Systemic signs were observed in one quarter of affected ewes, suggesting a role for supportive treatment. Clinical mastitis can be severe and challenging to fully resolve in New Zealand dairy sheep. CLINICAL RELEVANCE: This is the first systematic study of clinical mastitis in New Zealand dairy ewes. It provides baseline information specific to New Zealand conditions for farmers, veterinarians, and other advisors to guide the management of mastitis for the relatively new dairy sheep industry in New Zealand.
Subclinical mastitis in New Zealand grazing dairy ewes 1: Prevalence and risk factors
(Elsevier Inc on behalf of the American Dairy Science Association, 2026-01-01) Chambers G; Lawrence K; Grinberg A; Velathanthiri N; Ridler A; Laven R
Our objectives were to describe subclinical mastitis and identify its risk factors among grazing dairy ewes in New Zealand. Gland-level milk samples were collected from ∼15 randomly selected ewes on each of 20 dairy sheep farms at early, mid, and late lactation in a repeated cross-sectional study. California Mastitis Tests (CMT; measured on a scale of 0, trace, 1, 2, or 3) and aerobic bacterial culture were performed at the gland level, and SCC at the ewe level using composite milk samples. Subclinical mastitis was defined at the ewe level as having 1 or 2 bacteriologically positive glands and SCC >500 × 103 cells/mL or a CMT score ≥1 (or both). Milk samples were collected from 893 ewes, and complete subclinical mastitis data were available for 856 ewes. Median (range) SCC was 128,000 (2,000–34,953,000) cells/mL. A CMT score ≥1 in one or both glands was found in 21.2% of ewes. Bacteria were isolated from 5.5% of glands, with the most common species being non-aureus staphylococci (4.0% of glands) and Staphylococcus aureus (0.6% of glands). The prevalence of subclinical mastitis was 6.4% (95% CI = 4.6%–8.7%) and was not strongly clustered within farms (intraclass correlation coefficient = 0.04). Ewes with moderate or severe teat end hyperkeratosis had 6.4 times higher odds of subclinical mastitis than ewes with no or mild hyperkeratosis, and ewes with asymmetric udders had 2.3 times higher odds. The odds declined across the 3 visits. The prevalence was low compared with studies of more intensively farmed ewes in the northern hemisphere, but the bacterial causes were consistent. Subclinical mastitis management should be focused at the ewe level before the farm level, given the weak clustering within farms. When addressing or preventing a subclinical mastitis challenge, producers should consider teat end hyperkeratosis and udder asymmetry as simple visual screening tools but not rely on them alone to identify ewes at risk of subclinical mastitis. We present new information for New Zealand grazing dairy ewes, examine udder asymmetry as a diagnostic tool for subclinical mastitis, and show that, although prevalence was lower in New Zealand, the dominant pathogens are consistent, supporting the broader relevance of these findings to international mastitis control, albeit with adaptations for pasture-based systems.
Subclinical mastitis in New Zealand grazing dairy ewes 2: Relationships among somatic cell count, California Mastitis Test, and milk culture, and risk factors for elevated aerobic plate count
(Elsevier Inc on behalf of the American Dairy Science Association, 2026-01-01) Chambers G; Lawrence K; Grinberg A; Velathanthiri N; Ridler A; Laven R
Our objectives were, in grazing dairy ewes, (1) to describe SCC, California Mastitis Test (CMT) score, and ewe-level milk aerobic plate count (APC), (2) to explore the relationship between CMT and SCC, (3) to identify risk factors for elevated APC, and (4) to find the optimal SCC threshold for diagnosis of IMI. Gland-level milk samples were collected from ∼15 randomly selected ewes on each of 20 New Zealand dairy sheep farms at early, mid, and late lactation in a repeated cross-sectional study. Aerobic bacterial culture and CMT (measured on a scale of 0, trace, 1, 2, or 3) were performed at the gland level, and SCC and APC at the ewe level using composite milk samples. Milk samples were collected from 893 ewes, 870 of which had complete SCC and culture data. Geometric mean SCC was 169,039 (95% CI: 153,921–185,641) cells/mL, varying between farms and decreasing across visits. A CMT score ≥1 in one or both glands occurred in 21.2% of ewes. Mean log10 SCC increased linearly with CMT score, but the correlation between the ewe's highest gland-level CMT score and SCC was moderate (Kendall's tau = 0.47, 95% CI 0.43–0.52). Bacteria were isolated from 86 (9.9%) ewes, with the most common bacteria being NAS (7.0% of glands) and Staphylococcus aureus (0.6% of glands). A SCC threshold of ∼400,000 cells/mL had the greatest Youden's index for diagnosing IMI using a single SCC measurement. The APC was below the limit of quantification (1 × 103 cfu/mL) in 78.0% of ewes, and <100 × 103 cfu/mL in 96.9% of ewes, and varied between visits and farms. Using a mixed Bayesian ordinal regression model, elevated CMT score and SCC, positive milk culture, and subclinical mastitis, but not udder asymmetry, were confirmed as risk factors for elevated APC. These findings provide baseline milk quality data for New Zealand grazing dairy ewes, confirm that udder health should be considered when investigating elevated bulk milk APC, and can be used to help producers manage SCC, subclinical mastitis, and APC, as well as informing further research. Findings specific to New Zealand's emerging sheep dairy industry offer a benchmark for pastoral systems internationally and highlight the importance of udder health to bulk milk quality.